The Q1 2025 report projected that by the second half of 2025, two suppliers were expected to be providing fully domestic cells, modules and containers. Now Anza forecasts there will be three BESS ...

today announced the initiation of a Phase 2 clinical trial of its investigational oral PD-L1 inhibitor, OX-4224, in patients with non-small cell lung cancer (NSCLC). OX-4224 is an investigational ...

DORCHESTER COUNTY, S.C. (WCBD) – An inmate was quickly captured Monday morning after escaping from his cell. Steven Wright, public information officer for the Dorchester County Sheriff’s ...

cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off-the-shelf therapies for haematological cancers. The two companies will collaborate on the ...

Enzymes in the environment and in our bodies are quick to chop mRNA into pieces, making lab experiments difficult and the delivery of mRNA to our cells daunting. On top of that, mRNA strands are ...

Kerr Neilson, the veteran stockpicker who founded Platinum Asset Management three decades ago, says a merger with L1 Capital would turn around the storied investment firm by reinvigorating a ...

Small cell prostate cancer is a rare type of prostate cancer. Less than 2 in every 100 prostate cancers (less than 2%) are small cell prostate cancer. They are a type of neuroendocrine prostate cancer ...

For each tumor-pathway cohort, Simon’s two-stage design was used to make a preliminary assessment of treatment activity. For treatment-resistant tumor types (eg, non–small-cell lung cancer [NSCLC] and ...

According to the Mayo Clinic, hemoglobin is a protein in your red blood cells that transports oxygen ... The typical dose of berberine is 500 milligrams (mg) two to three times a day, Foroutan ...

NEW YORK, May 8, 2025 — Yamo Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to treating the core symptoms of autism spectrum disorder (ASD), today announced positive Phase 2 ...